ELAB vs XEL · rev $2.0M vs P/E 20, $39.33B cap
Elevai Labs, Inc. Common Stock (ELAB) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
XEL does not have a complete income-statement cache yet.
ELAB currently screens at market cap $6.5M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the ELAB and XEL stock pages for the full models.
Not investment advice.